OZEM 240920 28.00P (OZEM240920P28000) Stock Options, News & Quotes

US OptionsDetailed Quotes

OZEM240920P28000

Watchlist

0.20
-1.40-87.50%

15min DelayClose Sep 13 16:00 ET

0.20High0.20Low

Intraday

5D
Daily

News

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
BenzingaJul 18 16:59 ET
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
BenzingaJun 7 10:42 ET
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
BenzingaMay 30 15:36 ET
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
BenzingaMay 23 19:02 ET
Roundhill Investments Launches GLP-1 & Weight Loss ETF
BenzingaMay 21 09:42 ET

Comments

BelleWeather

Jul 17 08:04

Mann Kind

I continue to hold a position in $MannKind (MNKD.US)$ which is doing well. The company has a focus on metabolic diseases. I plan to sell the contracts in September (or when they hit my target percentage.) The shares I will hold for the time being, but may sell in favor of a basket such as the $Roundhill GLP-1 & Weight Loss ETF (OZEM.US)$ ETF, depending whether MNKD continues to have attractive financials and whether I am willing to pay the management fee.
#Trading Journal

Share Your Profit/Loss

74170476

May 21 20:40

$Roundhill GLP-1 & Weight Loss ETF (OZEM.US)$ Hello World